Latest news with #OrchidFertility
Khaleej Times
21-05-2025
- Business
- Khaleej Times
Orchid Fertility unveils advanced facility in Dubai Healthcare City
Orchid Fertility has moved into a state-of-the-art facility in Dubai Healthcare City. This move enhances the clinic's capacity and infrastructure, driven by sustained annual growth and rising demand —further cementing Dubai's status as a global hub for specialised healthcare. 'Orchid is a key asset within Waha Health, our healthcare investment platform and this milestone reflect the business's strong execution and sustained growth trajectory,' said Mohamed Hussain Al Nowais, Managing Director at Waha Capital. 'We are proud to support Orchid's continued expansion as it strengthens its market position and delivers long-term value through clinical excellence, innovation and a deeply patient-centric approach.' The newly launched clinic is designed to provide a streamlined, supportive, and deeply personalized fertility journey. It features an advanced IVF lab with cutting-edge embryology and andrology labs, private consultation rooms, recovery suites, and dedicated spaces for emotional and wellness support—recognizing that fertility is as much an emotional experience as it is a medical one. 'At Orchid, our work begins with empathy and is guided by science,' said Dr. Dimitrios Kafetzis, Medical Director and Consultant in Reproductive Endocrinology and Infertility at Orchid Fertility. 'This new facility enables us to deepen that commitment, offering improved outcomes and comfort to patients. Whether someone is taking their first steps in fertility treatment or seeking answers after a long journey, Orchid is where hope finds direction.' Known for its clinical excellence and compassionate approach, Orchid Fertility boasts one of the highest success rates in the UAE—with a 71% pregnancy rate across all age groups, well above industry averages. Its team of leading fertility specialists are highly experienced in treating complex cases, using the latest technology and evidence-based approaches to deliver hope and results to couples who have struggled for years. 'Dubai is a city that thrives on innovation, excellence and inclusivity,' said Dr. Arpan David, CEO of Orchid Fertility. 'It's the perfect place for us to continue our growth journey. Our team, infrastructure, and medical capabilities have evolved to support every patient with personalised, high-quality care.' The clinic's services include fertility preservation, male infertility treatment, genetic testing, embryo freezing, and advanced IVF procedures—all backed by a multidisciplinary team and supported by a compassionate care model. Beyond medicine, Orchid offers holistic support including counseling, mindfulness sessions, and lifestyle coaching to ease the emotional toll of fertility treatment. 'The rising demand for fertility care reflects changing lifestyles, delayed parenthood and greater awareness,' added Dr. Partha Das, Deputy Medical Director, Consultant Reproductive Endocrinology and Infertility. 'Orchid's enhanced capabilities ensure that we're well-positioned to extend care to a broader and more diverse group of patients—especially those who have experienced setbacks or are navigating complex fertility challenges.' With expanded capacity and streamlined scheduling, patients can now access consultations faster than ever before. 'At Orchid, we don't just offer treatment—we offer hope, direction, and unwavering support,' said Dr. Arpan David. 'This new facility is a reflection of our values: advanced, warm, and deeply human.' As demand for fertility services continues to grow across the UAE, Orchid Fertility's expansion marks a bold step forward in shaping the future of reproductive health—where innovation meets empathy, and outcomes change lives. Orchid's growth reflects Waha Capital's broader ambition to scale its healthcare investment platform and invest in businesses with scalable, impact-driven models. Orchid Fertility is accredited by the College of American Pathologists (CAP) and Joint Commission International (JCI) —globally recognized seals of excellence that reflect Orchid's excellence across clinical practices, infrastructure, and operations.
Zawya
21-05-2025
- Business
- Zawya
Orchid Fertility unveils advanced facility in Dubai Healthcare City, redefining fertility care in the Middle East
With cutting-edge tech, compassionate care, and one of the region's highest IVF success rates, Orchid aims to redefine fertility care in the Middle East. Dubai, UAE – Orchid Fertility, one of the region's most trusted names in reproductive health, has moved into a state-of-the-art facility in Dubai Healthcare City, designed to elevate patient experience and outcomes. This move enhances the clinic's capacity and infrastructure, driven by sustained annual growth and rising demand for high-quality, patient-centered fertility services—further cementing Dubai's status as a global hub for specialised healthcare. The facility was inaugurated in the presence of senior dignitaries from the UAE's healthcare sector, including officials from the Dubai Healthcare City Authority, the Managing Director and senior executives of Waha Capital as Orchid's shareholder, and the clinic's leadership team 'Orchid is a key asset within Waha Health, our healthcare investment platform and this milestone reflect the business's strong execution and sustained growth trajectory,' said Mr. Mohamed Hussain Al Nowais, Managing Director at Waha Capital. 'We are proud to support Orchid's continued expansion as it strengthens its market position and delivers long-term value through clinical excellence, innovation and a deeply patient-centric approach.' The newly launched clinic is designed to provide a streamlined, supportive, and deeply personalized fertility journey. It features an advanced IVF lab with cutting-edge embryology and andrology labs, private consultation rooms, recovery suites, and dedicated spaces for emotional and wellness support—recognizing that fertility is as much an emotional experience as it is a medical one. 'At Orchid, our work begins with empathy and is guided by science,' said Dr. Dimitrios Kafetzis, Medical Director and Consultant in Reproductive Endocrinology and Infertility at Orchid Fertility. 'This new facility enables us to deepen that commitment, offering improved outcomes and comfort to patients. Whether someone is taking their first steps in fertility treatment or seeking answers after a long journey, Orchid is where hope finds direction.' Known for its clinical excellence and compassionate approach, Orchid Fertility boasts one of the highest success rates in the UAE—with a 71% pregnancy rate across all age groups, well above industry averages. Its team of leading fertility specialists are highly experienced in treating complex cases, using the latest technology and evidence-based approaches to deliver hope and results to couples who have struggled for years. 'Dubai is a city that thrives on innovation, excellence and inclusivity,' said Dr. Arpan David, CEO of Orchid Fertility. 'It's the perfect place for us to continue our growth journey. Our team, infrastructure, and medical capabilities have evolved to support every patient with personalised, high-quality care.' The clinic's services include fertility preservation, male infertility treatment, genetic testing, embryo freezing, and advanced IVF procedures—all backed by a multidisciplinary team and supported by a compassionate care model. Beyond medicine, Orchid offers holistic support including counseling, mindfulness sessions, and lifestyle coaching to ease the emotional toll of fertility treatment. 'The rising demand for fertility care reflects changing lifestyles, delayed parenthood and greater awareness,' added Dr. Partha Das, Deputy Medical Director, Consultant Reproductive Endocrinology and Infertility. 'Orchid's enhanced capabilities ensure that we're well-positioned to extend care to a broader and more diverse group of patients—especially those who have experienced setbacks or are navigating complex fertility challenges.' With expanded capacity and streamlined scheduling, patients can now access consultations faster than ever before. 'At Orchid, we don't just offer treatment—we offer hope, direction, and unwavering support,' said Dr. Arpan David. 'This new facility is a reflection of our values: advanced, warm, and deeply human.' As demand for fertility services continues to grow across the UAE, Orchid Fertility's expansion marks a bold step forward in shaping the future of reproductive health—where innovation meets empathy, and outcomes change lives. Orchid's growth reflects Waha Capital's broader ambition to scale its healthcare investment platform and invest in businesses with scalable, impact-driven models. Orchid Fertility is accredited by the College of American Pathologists (CAP) and Joint Commission International (JCI) —globally recognized seals of excellence that reflect Orchid's excellence across clinical practices, infrastructure, and operations.
Zawya
29-04-2025
- Health
- Zawya
Orchid Fertility eliminates embryo biopsy risks with advanced genetic testing
Dubai, UAE – Orchid Fertility Dubai is at the forefront of reproductive technology with an innovative answer to one of the biggest challenges in assisted reproduction—i.e., the selection of the healthiest embryos while eliminating risks associated with traditional testing methods. With the introduction of Non-Invasive Preimplantation Genetic Testing (niPGT), Orchid Fertility is transforming the IVF experience to boost the likelihood of a successful pregnancy and minimize stress on embryos. Defective embryo genetics are among the primary causes of miscarriage, IVF failure, and birth defects. Technological advancements now offer new hope, though. Preimplantation Genetic Testing (PGT) allows doctors to screen embryos before implantation, so only the healthiest are selected., involves a biopsy—a process that extracts cells from the embryo to test which inevitably puts a small stress on the embryos. "Through the use of Non-Invasive Preimplantation Genetic Testing, we can analyze an embryo's genetic composition without the need for a biopsy," stated Dr. Dimitrios Kafetzis, Medical Director and Founding Doctor at Orchid Fertility Dubai. "This technology bypasses any risk, thereby allowing us to give our patients peace of mind and still provide information on their embryos" The niPGT method relies on the analysis of the DNA that the embryo naturally releases into the culture medium as it grows. This non-invasive approach enables specialists to screen for chromosomal abnormalities without compromising the structural integrity of the embryo. This technology is especially useful for women over 35 years of age, and those with multiple failed IVF cycles due to unexplained implantation failure. Orchid Fertility offers a complete set of genetic screening services, such as PGT-A for chromosome abnormalities like Down syndrome, PGT-M for monogenic conditions like sickle cell anemia and cystic fibrosis, PGT-SR for chromosomal translocations, and Carrier Screening for inherited disorders. "Selecting the most suitable embryo for implantation has long been an important aspect of in vitro fertilization; and we are always looking for a less invasive alternative to PGTA." NiPT is not a substitute of PGTA, but a screening tool to select the best embryos. Together with the latest generation embryoscope. Orchid Fertility is making best-in-class reproductive medicine accessible to families and thereby providing them with the greatest chance of having a healthy baby. About Orchid Fertility Orchid Fertility, part of Waha Health and located in the heart of Dubai Healthcare City, sets the benchmark for high-quality fertility care across the United Arab Emirates. The clinic is dedicated to providing evidence-based fertility treatments that meet international standards, offering couples the best possible chance of realizing their dream of having a healthy baby. With a holistic approach to fertility, Orchid Fertility emphasizes the importance of balancing the emotional, physical, and mental well-being of couples, recognizing that successful fertility treatment requires more than just medical intervention. The clinic's personalized care ensures that each couple's individual needs are met, including considerations of diet, stress management, and lifestyle improvements. Orchid Fertility is committed to enhancing the quality of life for couples seeking fertility assistance, with a focus on achieving healthy pregnancies and fostering the development of strong, healthy families. The clinic adheres to rigorous international quality standards, combining top-tier expertise with the latest advancements in technology, all while delivering compassionate and patient-centered care.
Khaleej Times
27-02-2025
- Health
- Khaleej Times
UAE: After losing first baby to rare genetic disorder, Dubai couple welcomes miracle child via IVF
When Aysha and Ahmed (names changed upon request) married in 2019, they were excited about their future and planned to grow their family. Aysha soon conceived, and the couple was overjoyed. However, their happiness was short-lived as one of the several tests during pregnancy revealed that the foetus was affected by Beckwith-Wiedemann Syndrome (BWS). The couple's first child did not survive. Beckwith-Wiedemann Syndrome is a genetic condition that causes excessive growth in different body parts. Babies born with BWS are often larger than usual, and some may experience disproportionate growth on one side of the body, a condition known as hemihyperplasia. Although children affected by BWS may grow taller than their peers, the condition typically slows down by age 8, and adult height tends to be normal. Despite the promising recovery with age, BWS increases the risk of childhood cancers, making it a difficult condition for parents. Aysha and Ahmed, originally from Jordan and long-time residents of Dubai, were heartbroken after losing their first child. But they were determined not to let the condition affect their future children. 'We learned that one of us carried the genetic mutation for BWS. We really wanted a healthy pregnancy and child, so we decided to go for in vitro fertilisation (IVF),' said Aysha. After undergoing IVF treatment, Aysha and Ahmed were able to welcome a healthy baby boy. Their son was free from the genetic disorder thanks to advanced fertility treatments and genetic testing. "We are very happy that our son is healthy and disease-free," said the mother. The couple consulted doctors at Orchid Fertility Clinic, where the team used Preimplantation Genetic Testing for Monogenic Diseases (PGT-M) to prevent the hereditary condition from being passed down. Dr Dimitrios Kafetzis, the medical director at Orchid Fertility, explained the challenges the couple faced, including advanced maternal age and a history of miscarriages. 'Our team employed a combination of advanced genetic screening and IVF techniques to help the couple conceive a healthy child while minimising the risk of passing on BWS,' said Dr Kafetzis. The IVF process began with ovarian stimulation over four cycles, resulting in the retrieval of 57 mature eggs. These eggs were fertilised via Intracytoplasmic Sperm Injection (ICSI), and 41 embryos developed. 'Genetic testing identified seven embryos that were free of the BWS mutation, and further screening for chromosomal abnormalities narrowed the selection down to two viable embryos, one of which was successfully implanted,' said Dr Kafetzis. 'The pregnancy progressed well, and the baby was born healthy,' said Maria Banti, lab director at Orchid Fertility. 'This case demonstrates the potential of reproductive genetics in preventing inherited conditions and ensuring better outcomes for families facing genetic challenges.' Now, the couple is determined to expand their family. They have embarked on their second round of IVF, hopeful that they will be blessed with another child free from genetic disorders.
